166 related articles for article (PubMed ID: 32611259)
1. Acylation of the antimicrobial peptide CAMEL for cancer gene therapy.
Song J; Ma P; Huang S; Wang J; Xie H; Jia B; Zhang W
Drug Deliv; 2020 Dec; 27(1):964-973. PubMed ID: 32611259
[TBL] [Abstract][Full Text] [Related]
2. Improving NK1R-targeted gene delivery of stearyl-antimicrobial peptide CAMEL by conjugating it with substance P.
Song J; Huang S; Ma P; Zhang B; Jia B; Zhang W
Bioorg Med Chem Lett; 2020 Aug; 30(16):127353. PubMed ID: 32631551
[TBL] [Abstract][Full Text] [Related]
3. Acylation of antimicrobial peptide-plasmid DNA vectors formulation for efficient gene delivery in cancer therapy.
Li Y; Sun Y; Dong W; Zhu C; Guan Y; Shang D
Colloids Surf B Biointerfaces; 2021 Dec; 208():112069. PubMed ID: 34478957
[TBL] [Abstract][Full Text] [Related]
4. Stearylated antimicrobial peptide melittin and its retro isomer for efficient gene transfection.
Zhang W; Song J; Liang R; Zheng X; Chen J; Li G; Zhang B; Yan X; Wang R
Bioconjug Chem; 2013 Nov; 24(11):1805-12. PubMed ID: 24107137
[TBL] [Abstract][Full Text] [Related]
5. Cancer gene therapy mediated by RALA/plasmid DNA vectors: Nitrogen to phosphate groups ratio (N/P) as a tool for tunable transfection efficiency and apoptosis.
Neves AR; Sousa A; Faria R; Albuquerque T; Queiroz JA; Costa D
Colloids Surf B Biointerfaces; 2020 Jan; 185():110610. PubMed ID: 31711736
[TBL] [Abstract][Full Text] [Related]
6. Influence of chain length on the anticancer activity of the antimicrobial peptide CAMEL with fatty acid modification.
Ma L; Huang S; Xie H; Ma P; Jia B; Yao Y; Gao Y; Li W; Song J; Zhang W
Eur J Med Chem; 2022 Sep; 239():114557. PubMed ID: 35759906
[TBL] [Abstract][Full Text] [Related]
7. Viral vector mimicking and nucleus targeted nanoparticles based on dexamethasone polyethylenimine nanoliposomes: Preparation and evaluation of transfection efficiency.
Malaekeh-Nikouei B; Gholami L; Asghari F; Askarian S; Barzegar S; Rezaee M; Kazemi Oskuee R
Colloids Surf B Biointerfaces; 2018 May; 165():252-261. PubMed ID: 29494955
[TBL] [Abstract][Full Text] [Related]
8. Acid-activated nonviral peptide vector for gene delivery.
Ji K; Xiao Y; Zhang W
J Pept Sci; 2020 Jan; 26(1):e3230. PubMed ID: 31696619
[TBL] [Abstract][Full Text] [Related]
9. P53-Derived peptides conjugation to PEI: an approach to producing versatile and highly efficient targeted gene delivery carriers into cancer cells.
Mokhtarzadeh A; Parhiz H; Hashemi M; Abnous K; Ramezani M
Expert Opin Drug Deliv; 2016; 13(4):477-91. PubMed ID: 26654047
[TBL] [Abstract][Full Text] [Related]
10. Co-delivery of p53 and MDM2 inhibitor RG7388 using a hydroxyl terminal PAMAM dendrimer derivative for synergistic cancer therapy.
Chen K; Xin X; Qiu L; Li W; Guan G; Li G; Qiao M; Zhao X; Hu H; Chen D
Acta Biomater; 2019 Dec; 100():118-131. PubMed ID: 31568878
[TBL] [Abstract][Full Text] [Related]
11. Novel luminescent silica nanoparticles (LSN): p53 gene delivery system in breast cancer in vitro and in vivo.
Rejeeth C; Salem A
J Pharm Pharmacol; 2016 Mar; 68(3):305-15. PubMed ID: 27085860
[TBL] [Abstract][Full Text] [Related]
12. New generation of efficient peptide-based vectors, NickFects, for the delivery of nucleic acids.
Arukuusk P; Pärnaste L; Oskolkov N; Copolovici DM; Margus H; Padari K; Möll K; Maslovskaja J; Tegova R; Kivi G; Tover A; Pooga M; Ustav M; Langel U
Biochim Biophys Acta; 2013 May; 1828(5):1365-73. PubMed ID: 23357356
[TBL] [Abstract][Full Text] [Related]
13. A novel, bio-reducible gene vector containing arginine and histidine enhances gene transfection and expression of plasmid DNA.
Tanaka K; Kanazawa T; Ogawa T; Suda Y; Takashima Y; Fukuda T; Okada H
Chem Pharm Bull (Tokyo); 2011; 59(2):202-7. PubMed ID: 21297300
[TBL] [Abstract][Full Text] [Related]
14. Novel biomimetic vectors with endosomal-escape agent enhancing gene transfection efficiency.
Sun X; Liu C; Liu D; Li P; Zhang N
Int J Pharm; 2012 Apr; 425(1-2):62-72. PubMed ID: 22266532
[TBL] [Abstract][Full Text] [Related]
15. Enhanced p53 gene transfer to human ovarian cancer cells using the cationic nonviral vector, DDC.
Kim CK; Choi EJ; Choi SH; Park JS; Haider KH; Ahn WS
Gynecol Oncol; 2003 Aug; 90(2):265-72. PubMed ID: 12893186
[TBL] [Abstract][Full Text] [Related]
16. TRIAD1 Is a Novel Transcriptional Target of p53 and Regulates Nutlin-3a-Induced Cell Death.
Lee J; An S; Choi YM; Jung JH; Li L; Meng H; Dong Y; Ahn KJ; An IS; Bae S
J Cell Biochem; 2017 Jul; 118(7):1733-1740. PubMed ID: 27935098
[TBL] [Abstract][Full Text] [Related]
17. A spermine conjugated stearic acid-g-chitosan oligosaccharide polymer with different types of amino groups for efficient p53 gene therapy.
Meng T; Wu J; Yi H; Liu J; Lu B; Yuan M; Huang X; Yuan H; Hu F
Colloids Surf B Biointerfaces; 2016 Sep; 145():695-705. PubMed ID: 27289311
[TBL] [Abstract][Full Text] [Related]
18. Reduction-responsive cross-linked stearyl peptide for effective delivery of plasmid DNA.
Yao C; Tai Z; Wang X; Liu J; Zhu Q; Wu X; Zhang L; Zhang W; Tian J; Gao Y; Gao S
Int J Nanomedicine; 2015; 10():3403-16. PubMed ID: 26056440
[TBL] [Abstract][Full Text] [Related]
19. Bioengineered silk gene delivery system for nuclear targeting.
Yigit S; Tokareva O; Varone A; Georgakoudi I; Kaplan DL
Macromol Biosci; 2014 Sep; 14(9):1291-8. PubMed ID: 24889658
[TBL] [Abstract][Full Text] [Related]
20. Avidin-biotin interaction mediated peptide assemblies as efficient gene delivery vectors for cancer therapy.
Qu W; Chen WH; Kuang Y; Zeng X; Cheng SX; Zhou X; Zhuo RX; Zhang XZ
Mol Pharm; 2013 Jan; 10(1):261-9. PubMed ID: 23146022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
